Bayer was founded in the year 1863 in Barmen in North Rhine Westphalia in the west of what was then the Kingdom of Prussia, today modern Germany. "What started as a small but innovative dyestuffs ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
It's worth noting that Bayer has its own PSMA-targeting thorium-227 drug – BAY 2315497 – in phase 1 development, which uses an antibody for tumour targeting.
The global diabetic retinopathy market was valued at $3.09 billion in 2020 and is projected to reach $10.79 billion by 2030, growing at a robust CAGR of 13.7%.
DiveWire guarantees visibility for your news announcements through instant distribution to BioPharma Dive’s audience and its 153,500 newsletter subscribers for 21 days.
The global vascular ulcer treatment market is on an impressive growth trajectory, with recent forecasts estimating its value to soar from USD 2,737.4 million in 2023 to an anticipated USD 4,344 ...
SE Kjeldsen has received honoraria from AstraZeneca, Bayer, Boehringer-Ingelheim, Leo, Medtronic, Nycomed and Takeda, and also moderate research support from AstraZeneca and Pronova. The authors ...
including ovarian steroids, the hypothalamic–pituitary–adrenal axis, the serotonergic neurotransmitter system, the thyroid system and inflammatory markers. In addition, current knowledge on ...